FP7
RAPP-ID
Development of RApid Point-of-Care test Platforms for Infectious Diseases
- Programme
- Seventh Framework Programme
- Started
- Ends
- Duration
- 66 months
- Total cost
- EUR 15,927,300
- EU contribution
- EUR 6,828,438
- Participants
- 20 from 10 countries
- Topic
- FP7_IMI-JU-02-2009-04
- Grant agreement
- 115153
Coordinated by Janssen Pharmaceutica NV (BEBelgium).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Janssen Pharmaceutica NV | BEBelgium | Coordinator | Not stated | PIC (1.00) |
| Interuniversitair Micro-Electronica Centrum | BEBelgium | Participant | EUR 229,726 | PIC (1.00) |
| Katholieke Universiteit Leuven | BEBelgium | Participant | EUR 366,540 | PIC (1.00) |
| Universiteit Antwerpen | BEBelgium | Participant | EUR 1,272,684 | known name (0.95) |
| Universiteit Gent | BEBelgium | Participant | EUR 458,075 | known name (0.95) |
| Universite de Geneve | CHSwitzerland | Participant | EUR 60,500 | known name (0.95) |
| Lionex GmbH | DEGermany | Participant | EUR 476,900 | PIC (1.00) |
| Microfluidic Chipshop GmbH | DEGermany | Participant | EUR 467,400 | PIC (1.00) |
| Mobidiag Oy | FIFinland | Participant | EUR 174,455 | PIC (1.00) |
| Sanofi-Aventis Recherche & Developpement | FRFrance | Participant | Not stated | PIC (1.00) |
| Cardiff University | GBUnited Kingdom | Participant | EUR 75,379 | known name (0.95) |
| Glaxosmithkline Research & Development Limited | GBUnited Kingdom | Participant | Not stated | PIC (1.00) |
| The Chancellor Masters and Scholars of the University of Cambridge | GBUnited Kingdom | Participant | EUR 489,154 | known name (0.95) |
| Glaxosmithkline Vaccines SRL | ITItaly | Participant | Not stated | PIC (1.00) |
| Universiteit Twente | NLNetherlands | Participant | EUR 364,003 | known name (0.95) |
| Kungliga Tekniska Hoegskolan | SESweden | Participant | EUR 1,327,277 | PIC (1.00) |
| Q-linea | SESweden | Participant | EUR 491,845 | PIC (1.00) |
| Stockholms Universitet | SESweden | Participant | EUR 537,377 | known name (0.95) |
| Uppsala Universitet | SESweden | Participant | EUR 37,123 | known name (0.95) |
| Merck Sharp & Dohme Corp | USUnited States | Participant | Not stated | PIC (1.00) |
Changes of the consortium
First seen on with 20 participants from 10 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.